Showing results (61-70 of 222) with videos related to

Sort By:
Pageof 23
Journal of Viral Hepatitis|July 26, 2014
Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferonL Boglione, J Cusato, A De Nicolò, et al.
Le Infezioni in Medicina|June 28, 2002
A case of flare syndromeA Maiello, D Racca, D A Zeme, et al.
Journal of Viral Hepatitis|March 7, 2014
Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevirL Boglione, A De Nicolò, J Cusato, et al.
Minerva Anestesiologica|December 17, 2008
Invasive candidiasis and candidemia: new guidelinesF G De Rosa, S Garazzino, D Pasero, et al.
Minerva Medica|December 15, 1983
[Markers of viral hepatitis B. Diagnostic, prognostic and therapeutic relevance]S Vento, V Salpietro, E Russomanno
Drugs Under Experimental and Clinical Research|January 1, 1988
Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteersM Cruciani, V Monzillo, A Navarra, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Availability of synthetic salmon calcitonin in tissue fluid after a single intravenous doseE Concia, M Cruciani, F Bartucci, et al.
Microbiologica|April 1, 1987
Antistaphylococcal activity of teicoplanin in association with other antibioticsM Cruciani, E Concia, V Monzillo, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1985
Costs and benefits of diagnostic and therapeutic methods in Salmonella infectionsD Scevola, G Barbarini, E Concia, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1990
Treatment of bone and soft tissue infections with teicoplaninP Marone, E Concia, M Andreoni, et al.
Pageof 23